ASLAN Pharmaceuticals Limited
ASLN · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$44,220 | -$51,283 | -$31,591 | -$16,971 |
| Dep. & Amort. | $348 | $332 | $282 | $298 |
| Deferred Tax | -$8,266 | $0 | -$2,621 | $126 |
| Stock-Based Comp. | $2,703 | $1,977 | $2,193 | $346 |
| Change in WC | -$2,952 | $9,352 | -$4,121 | -$98 |
| Other Non-Cash | $6,026 | $1,218 | $1,861 | $1,247 |
| Operating Cash Flow | -$46,360 | -$38,405 | -$33,996 | -$15,053 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$11 | -$27 | -$49 | -$5 |
| Net Acquisitions | $0 | $1 | $0 | $1 |
| Inv. Purchases | $0 | -$16,513 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $16,600 | $0 | $0 |
| Other Inv. Act. | $0 | $353 | $21 | $5 |
| Investing Cash Flow | -$11 | $415 | -$28 | $1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $23,028 | $0 | $101,556 | $7,643 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $10,720 | $4,725 | $109,867 | $7,173 |
| Financing Cash Flow | $10,720 | $4,725 | $109,867 | $7,173 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$35,650 | -$33,266 | $75,844 | -$7,879 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $56,902 | $90,168 | $14,324 | $22,203 |
| End Cash | $21,252 | $56,902 | $90,168 | $14,324 |
| Free Cash Flow | -$46,371 | -$38,432 | -$34,044 | -$15,058 |